Department of Otolaryngology, University of Toyama, Toyama, Japan.
Head Neck. 2013 Apr;35(4):E131-7. doi: 10.1002/hed.21976. Epub 2011 Dec 16.
The prognosis for patients with mucosal malignant melanoma (MMM) of the nasal cavity is very poor because of the radioresistance of melanoma cells.
We present the first case report of the efficacy of superselective intra-arterial cisplatin (CDDP) infusion concurrent with hypofractionated radiotherapy (RT) for MMM of the nasal cavity.
A pink, polypoid mass, histopathologically diagnosed as an amelanostic melanoma, occupied the right nasal cavity. After the treatment, a nasal tumor disappeared, leaving only a small bulge in the medial wall of the middle turbinate. Histopathologic examination revealed scattered degenerated melanoma cells, remaining only in the small restricted area in the medial surface of the excised middle turbinate. Twelve months after the treatment, the patient has not experienced any local recurrence or regional and distant metastasis.
The superselective intra-arterial CDDP infusion concurrent with hypofractionated RT might be useful for the management of nasal MMM.
鼻腔黏膜恶性黑色素瘤(MMM)患者的预后非常差,因为黑色素瘤细胞对放疗具有抵抗力。
我们首次报告了鼻腔 MMM 采用超选择性动脉内顺铂(CDDP)输注联合低分割放疗(RT)的疗效。
一个粉红色的息肉状肿块,组织病理学诊断为无黑色素性黑色素瘤,占据了右侧鼻腔。治疗后,鼻腔肿瘤消失,中鼻甲内侧壁仅留下一个小隆起。组织病理学检查显示,散在退化的黑色素瘤细胞仅存在于切除的中鼻甲内侧表面的小受限区域内。治疗 12 个月后,患者未出现局部复发或区域及远处转移。
超选择性动脉内 CDDP 输注联合低分割 RT 可能对鼻腔 MMM 的治疗有用。